Baker Avenue Asset Management, LP Novartis Ag Transaction History

Baker Avenue Asset Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $5,683 - $6,307	-60 Reduced 13.42%	387 $39,000
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $1,480 - $1,678	16 Added 3.71%	447 $45,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $2,320 - $2,691	-29 Reduced 6.3%	431 $39,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $34,753 - $42,559	460 New	460 $41,000
Q2 2022 Aug 03, 2022	SELL	$80.52 - $93.75 $350,745 - $408,375	-4,356 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $76,585 - $86,632	956 Added 28.12%	4,356 $382,000
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $19,606 - $21,679	246 Added 7.8%	3,400 $297,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $257,934 - $300,071	3,154 New	3,154 $257,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.